Industrial Research World

  The COVID-19 outbreak is continuing to create havoc all over the world and scientists are immensely involved to develop antidotes for the novel coronavirus, which started infecting people since late last year. Researchers and scientists are exploring several avenues to introduce the world with medical treatments that can thoroughly fight the COVID-19 disease. ‘Convalescent Plasma Therapy’ is one such treatment that is currently in focus around the globe. Presently, India has been given a go ahead for edging protocol after China and the U.S. in order to conduct a clinical trial for convalescent plasma therapy. This therapy has been already used as an experiment in the past and as a result is turning out to be a ray of hope in this war against the novel COVID-19 pandemic. What is Convalescent Plasma Therapy for Coronavirus and How Does it Work? The purpose of convalescent plasma therapy is to use antibodies from the blood of a COVID-19 recovered patient in order to treat those who are

  As per a new study conducted by Research Dive, the global plasma therapy market is predicted to reach up to   $432.8 million by 2026 , growing at a   CAGR of 16.3% during the forecast years 2019 to 2026.   The global market is classified into type, source, application, end use and region. The study provides complete overview of drivers, opportunities, restraints, segmental analysis and significant players in the global market.  This outbreak of coronavirus has positively impacted the global plasma therapy market and is expected to experience a considerable growth in the coronavirus outbreak. Due to coronavirus pandemic, scientists across the globe are emphasizing on several avenues to find successful treatment methods that will be able to fight against novel coronavirus. Also, researchers are majorly looking at plasma therapy procedures as a potential treatment for coronavirus. This factor is significantly driving demand for plasma therapy in the treatment of COVID-19 pandemic, which

  As per a new study conducted by Research Dive, the global plasma therapy market is predicted to reach up to $432.8 million by 2026, growing at a CAGR of 16.3% during the forecast years 2019 to 2026. The global market is classified into type, source, application, end use and region. The study provides complete overview of drivers, opportunities, restraints, segmental analysis and significant players in the global market.  Factors affecting the market growth As per our analysts, increasing demand for plasma therapy for the treatment of neurological patients due to growing awareness about personalized healthcare systems is mainly driving the market growth. However, high costs for the treatment of plasma therapy is a major restraint for the plasma therapy market growth. Pure platelet-rich plasma (PRP) type is anticipated to dominate the market in the near future The global market has been divided on the basis of type into pure platelet-rich plasma (PRP), leucocyte-rich PRP, leukocyte-ric